Navigation Links
Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
Date:9/3/2008

2005 after the merger of two leading century-old Japanese pharmaceutical companies, is a global pharmaceutical innovator, continuously generating innovative drugs that enrich the quality of life for patients around the world. The company uses its cumulative knowledge and expertise in the fields of cardiovascular disease, cancer, metabolic disorders, and infection as a foundation for developing an abundant product lineup and R&D pipeline.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

This press release contains certain forward-looking statements about the potential of the investigational compound prasugrel (CS-747, LY640315) and reflects Daiichi Sankyo's and Lilly's current beliefs. However, as with any pharmaceutical compound under development, there are substantial risks and uncertainties in the process of development and regulatory review. There is no guarantee that the compound will receive regulatory approval, that the regulatory approval will be for the indication(s) anticipated by the companies, or that later studies and patient experience will be consistent with study findings to date. There is also no guarantee that the compound will prove to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filing with the United States Securities and Exchange Commission and Daiichi Sankyo's filings with the Tokyo Stock Exchange. Daiichi Sankyo and Lilly undertake no duty to update forward-looking statements.

Plavix(R)/Iscover(R) are registered trademarks of sanofi-aventis.

P-LLY


'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel
2. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
3. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
4. TRITON-TIMI 38 Stent Analysis Favors Prasugrel
5. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies
8. Hibernation-On-Demand Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss
9. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
10. New Study: Pine Bark Significantly Reduces Menstrual Pain
11. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  Landauer, Inc. (NYSE: ... and environmental radiation measurement and monitoring, outsourced medical physics ... that William E. Saxelby , its President and ... and Chief Executive Officer and as a member of ... 2014.  He will be replaced on an interim basis ...
(Date:8/21/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... women,s health, has appointed Holly B. Bauzon ... Ms. Bauzon has a proven track record in ... laboratory services companies. She has more than 20 years ... she held the position of Director, Lab Services Sales ...
(Date:8/21/2014)... 21, 2014 /CNW/ - Eisai Limited is pleased to support ... first-of-its-kind comic book available in Canada . ... specifically to educate children and their parents about epilepsy, the ... affecting more than 300,000 Canadians. Eisai is guided by a ... in which the patient is central – there was a ...
Breaking Medicine Technology:Landauer, Inc. Announces Executive Management Change 2Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... 2012 Telepharmacy is helping pharmacies extend services ... staffing shortages experienced by many rural health care ... allows for a pharmacy technician to be remotely ... state-of-the-art telecommunications technology to prepare prescriptions. ...
... of high intensity focused ultrasound (HIFU) and focal therapy ... the focus of multiple research papers accepted for presentation ... Association (AUA), in Atlanta May 19-23, 2012.  According to ... invasive HIFU technologies, the studies bolster a growing interest ...
Cached Medicine Technology:Rural Health-Systems Benefit From Remote Pharmacy Technician Supervision 2Rural Health-Systems Benefit From Remote Pharmacy Technician Supervision 3US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA 2US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA 3
(Date:8/22/2014)... 2014 Top 10 Best SEO ... hosting companies and highly recommended FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ... manager of Top 10 Best SEO Hosting states, ... server hosting supplier. Actually, these companies have outperformed ... and customer support. People can get the best ...
(Date:8/22/2014)... With the stage set for the ... Expo - which will be held in Boston August ... in its online opinion section, Podium. The op-ed ... co-authored by Steven C. Anderson, IOM, CAE, president & ... the MCPHS University School of Pharmacy – Worcester/Manchester. ...
(Date:8/22/2014)... By Amy Norton ... (HealthDay News) -- A growing number of Americans on ... a new study. Researchers found that between 2007 ... Security Disability Insurance benefits were prescribed narcotic painkillers each ... from 21 percent in 2007 to 23 percent in ...
(Date:8/22/2014)... August 22, 2014 Millennium Treatment ... in Lantana, FL, recently launched a new website. ... for information can now find Millennium Treatment Group ... just went live at the beginning of July. ... facility can be found on the website. There’s ...
(Date:8/22/2014)... oncogenic somatic mutation at amino acid 918 in the ... small cell lung cancer (SCLC) tumors and enforced expression ... intracellular signaling and cell growth. , SCLC is a ... all lung cancers and is strongly associated with tobacco ... extensively examined for genomic alterations and targeted therapies are ...
Breaking Medicine News(10 mins):Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Millennium Treatment Group Has a New Website 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2
... February 2, 2009 -- "The state of America,s health ... of the American College of Physicians (ACP), reported today ... briefing. "There are too many uninsured and underinsured people. ... problems are big, so the solutions must also be ...
... WASHINGTON, Feb. 2 The Spastic Paraplegia Foundation ... Lateral Sclerosis (PLS) Awareness Month, part of a ... debilitating condition that affects tens of thousands of ... http://www.newscom.com/cgi-bin/prnh/20090202/PH65601LOGO )"It is important that we create ...
... Fellowship" to Focus on Auto Safety AdvocacyWASHINGTON, Feb. 2 ... for Highway and Auto Safety (Advocates) announced today the ... DC offices. The program aims to develop public ... organizations, abiding interest in highway and auto safety. ...
... immune system proteins could hold the key, study finds , , ... may someday help doctors treat and prevent colitis-associated cancer (CAC), ... a protein released by cells in the immune system, plays ... to a study on mice done at the University of ...
... Scientists today announced the discovery of 10 ... spiky-skinned, orange-legged rain frog, three poison dart frogs and ... can reveal internal organs. , The species were discovered ... Colombia,s mountainous Tacarcuna area of the Darien, near the ...
... Services, Inc. (NYSE: WST ) today announced that ... and William Federici, Chief Financial Officer, will be presenting at ... on February 10, 2009 in New York City. A copy ... investor link of the Company,s website at www.westpharma.com ...
Cached Medicine News:Health News:ACP: State of America's health care is poor 2Health News:ACP: State of America's health care is poor 3Health News:Foundation Kicks off First-Ever PLS Awareness Month 2Health News:Allstate and Advocates for Highway and Auto Safety Unveil Public Policy Fellowship Program 2Health News:Allstate and Advocates for Highway and Auto Safety Unveil Public Policy Fellowship Program 3Health News:Ten new amphibian species discovered in Colombia 2Health News:Ten new amphibian species discovered in Colombia 3
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated....
Barraquer needle holder, curved, delicate....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medicine Products: